PL2937424T3 - Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie - Google Patents

Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie

Info

Publication number
PL2937424T3
PL2937424T3 PL15164896T PL15164896T PL2937424T3 PL 2937424 T3 PL2937424 T3 PL 2937424T3 PL 15164896 T PL15164896 T PL 15164896T PL 15164896 T PL15164896 T PL 15164896T PL 2937424 T3 PL2937424 T3 PL 2937424T3
Authority
PL
Poland
Prior art keywords
same
lactic acid
composition containing
acid bacterium
bacterium
Prior art date
Application number
PL15164896T
Other languages
English (en)
Inventor
Ying-Chieh Tsai
Wei-Hsien Liu
jian-fu Liao
Chih-Chieh Hsu
Original Assignee
National Yang-Ming University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/259,442 external-priority patent/US10967013B2/en
Priority claimed from US14/690,502 external-priority patent/US10188684B2/en
Application filed by National Yang-Ming University filed Critical National Yang-Ming University
Publication of PL2937424T3 publication Critical patent/PL2937424T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
PL15164896T 2014-04-23 2015-04-23 Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie PL2937424T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/259,442 US10967013B2 (en) 2014-04-23 2014-04-23 Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same
US14/690,502 US10188684B2 (en) 2015-04-20 2015-04-20 Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium

Publications (1)

Publication Number Publication Date
PL2937424T3 true PL2937424T3 (pl) 2017-09-29

Family

ID=53008330

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15164896T PL2937424T3 (pl) 2014-04-23 2015-04-23 Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie

Country Status (5)

Country Link
EP (1) EP2937424B1 (pl)
JP (1) JP6035578B2 (pl)
CN (1) CN105002109B (pl)
ES (1) ES2624673T3 (pl)
PL (1) PL2937424T3 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6933358B2 (ja) * 2016-04-06 2021-09-08 東海漬物株式会社 美肌促進剤
JP6878565B2 (ja) * 2016-07-19 2021-05-26 ベネド バイオメディカル カンパニー リミテッド 乳酸菌による大脳基底核疾患、または、チック障害を治療または予防するための薬剤
KR20180019474A (ko) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法
JP6986288B2 (ja) * 2017-01-13 2021-12-22 ベネド バイオメディカル カンパニー リミテッド 新規乳酸菌およびその応用
KR102089836B1 (ko) * 2017-03-15 2020-03-16 (주)바이오일레븐 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법
CN106906165B (zh) * 2017-04-25 2020-07-24 重庆第二师范学院 一种植物乳杆菌及其在制备预防便秘的食品中的应用
CN107267416A (zh) * 2017-07-05 2017-10-20 重庆第二师范学院 植物乳杆菌ys2及其在制备预防便秘的食品中的应用
CA3085508A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
CA3089187A1 (en) * 2018-02-02 2019-08-08 Kobiolabs, Inc Lactobacillus plantarum kbl396 strain and use thereof
CN111035661A (zh) * 2018-10-15 2020-04-21 深圳市华大农业应用研究院 植物乳杆菌的用途
TWI731279B (zh) * 2018-11-21 2021-06-21 葡萄王生技股份有限公司 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途
ES2763350B2 (es) * 2018-11-28 2020-10-13 Consejo Superior Investigacion Cepa de christensenella minuta y uso de la misma
CA3120942A1 (en) * 2018-12-06 2020-06-11 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
TWI739291B (zh) * 2019-01-28 2021-09-11 益福生醫股份有限公司 保護個體運動之方法
JP2022518600A (ja) * 2019-02-01 2022-03-15 ベネド バイオメディカル カンパニー リミテッド 乳酸菌により非ヒト動物の異常な感情又は行動を予防又は治療する方法
US20220152126A1 (en) * 2019-02-01 2022-05-19 Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement Lactococcus lactis strains for the prevention and/or the treatment of visceral pain
KR102148707B1 (ko) * 2019-02-22 2020-08-31 한국식품연구원 우울증 및 불안장애의 예방, 개선 또는 치료 효능을 갖는 김치 유산균 락토바실러스 사케아이
WO2021155543A1 (en) * 2020-02-06 2021-08-12 Lee Wang Tso Composition of lactic acid bacterium for use in preventing or treating rett syndrome
TWI826851B (zh) * 2020-10-22 2023-12-21 國立臺灣大學 植物乳酸桿菌植物亞種ｐｓ１２８於製備治療芳香族l-胺基酸脫羧基酶缺乏症的藥物的用途
US20240058398A1 (en) * 2020-12-16 2024-02-22 Meiji Co., Ltd. Composition for improving inflammation of brain tissue
CN113215018A (zh) * 2021-02-04 2021-08-06 郑州大学 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用
CN113564084A (zh) * 2021-08-13 2021-10-29 华东理工大学 植物乳杆菌x7022在预防和治疗便秘上的应用
WO2024089260A1 (en) * 2022-10-28 2024-05-02 Chr. Hansen A/S Lactiplantibacillus plantarum for use in addressing the symptoms of irritable bowel syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725853A (en) * 1994-10-18 1998-03-10 Pioneer Hi-Bred International, Inc. 4 strain direct-fed microbial
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
WO2010021247A1 (ja) * 2008-08-21 2010-02-25 サントリーホールディングス株式会社 セロトニントランスポーター阻害活性を有する医薬品又は飲食品

Also Published As

Publication number Publication date
EP2937424B1 (en) 2017-03-29
ES2624673T3 (es) 2017-07-17
CN105002109B (zh) 2018-09-14
CN105002109A (zh) 2015-10-28
JP2015213501A (ja) 2015-12-03
EP2937424A1 (en) 2015-10-28
JP6035578B2 (ja) 2016-11-30

Similar Documents

Publication Publication Date Title
PL2937424T3 (pl) Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie
SG10202107425VA (en) Novel lactic acid bacteria and use thereof
SG11201802144TA (en) Novel lactobacillus having various functions, and use thereof
SG11201911984QA (en) Novel lactic acid bacteria and use thereof
IL249646B (en) Platinum compounds, preparations, and their uses
HK1232169A1 (zh) 取代的 -苯基哌啶，其製備和用途
IL246987B (en) Heteroaryl amides, preparations containing it and their uses
EP3362038A4 (en) COSMETIC COMPOSITION CONTAINING PROBIOTIC BACTERIA
EP3131131A4 (en) Light-emission element, and composition used therein
EP3133152A4 (en) Novel bacteriophage, and composition containing same
EP3715449C0 (en) NEW LACTIC BACTERIA AND THEIR USE
IL252397A0 (en) Pharmaceutical preparations, their preparation and uses
SG11202104408UA (en) Novel lactic acid bacteria and use thereof
IL290114A (en) Pharmaceutical preparations, their preparation and uses
HK1215004A1 (zh) 光觸媒組合物及含有該光觸媒組合物的光觸媒塗料組合物
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
HK1254379A1 (zh) 烯基苯氧基取代的1，1-二苯基乙烯、它們的製備方法和它們的用途
PT3229843T (pt) Composição farmacêutica, a sua preparação e as suas utilizações
IL252683B (en) Pyridyl-cycloalkyl-substituted carboxylic acids, preparations containing them and their medical uses
IL269546A (en) Lactic acid bacteria, methods and uses thereof
EP3165599A4 (en) Novel lactic acid bacterium and composition including said lactic acid bacterium
SG11201701577WA (en) Lactic acid bacteria-containing composition
RO130539B8 (ro) Compoziţie erbicidă, procedeu de preparare şi utilizarea acesteia
IL249122A0 (en) History of imidazole- or 4,2,1-triazole and their use
PT3166945T (pt) Derivados de triazolopirimidinona ou de triazolopiridinona inovadores e utilização dos mesmos